• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

CDER Forum for International Drug Regulatory Authorities, April 16-20, 2012, College Park, MD

The Center for Drug Evaluation and Research (CDER) will be presenting a revamped CDER Forum for International Drug Regulatory Authorities (CDER Forum) from April 16-20, 2012. In the past, CDER Forums provided an overview of CDER Offices. Recent CDER Forums have placed a greater emphasis on the review process. Specifically, CDER review disciplines have discussed a review that was posted on CDER's Drugs@FDA website. 

The 14th CDER Forum will focus on identification, evaluation, and monitoring of adverse events in three key areas of the drug life cycle: during clinical trials, FDA application review, and postmarket monitoring and analysis. This revamped CDER Forum will provide opportunities to learn from one another and promote discussion of common areas of concern. 

The CDER Forum will be held in College Park, Maryland. There is no registration fee for the program, however all attendees are responsible for their own travel and hotel expenses. 

Please direct any questions to the CDER Forum mailbox: CDERForum@fda.hhs.gov


Registration Information

Registration information and requests should be sent to CDERForum@fda.hhs.gov. As a reminder, the CDER Forum is intended for international drug regulatory authorities, and registration from non drug regulatory authorities will not be honored.

Please include the following information about the proposed attendee:

  • Name
  • Position
  • Title
  • Country and Drug Regulatory Authority
  • Address
  • Phone
  • E-mail
  • Topic/Area of Interest


For further information, contact:

Justina A. Molzon, MS Pharm, JD
Associate Director for International Programs
Center for Drug Evaluation and Research
United States Food and Drug Administration
U.S. Department of Health and Human Services
CDERForum@fda.hhs.gov